{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:33:29Z","timestamp":1786120409764,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008746","name":"National Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008746","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic Arizona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bioadv.2026.215015","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:41:12Z","timestamp":1781714472000},"page":"215015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hydrogel microtumor arrays of patient melanoma recapitulate phenotypes and drug sensitivity"],"prefix":"10.1016","volume":"188","author":[{"given":"Yiling","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Pawlush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna J.","family":"Gleba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella G.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin E.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina H.","family":"Stenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Copland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher A.","family":"Kilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.bioadv.2026.215015_bb0005","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJMoa2404139","article-title":"Final results for adjuvant dabrafenib plus trametinib in stage III melanoma","volume":"391","author":"Long","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bioadv.2026.215015_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041106","article-title":"Immunotherapy in melanoma: recent advances and future directions","volume":"15","author":"Knight","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.bioadv.2026.215015_bb0015","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1038\/s41596-024-00998-w","article-title":"OBSERVE: guidelines for the refinement of rodent cancer models","volume":"19","author":"De Vleeschauwer","year":"2024","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215015_bb0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7150\/thno.21674","article-title":"Current challenges of cancer anti-angiogenic therapy and the promise of nanotherapeutics","volume":"8","author":"Abdalla","year":"2018","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bioadv.2026.215015_bb0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41392-023-01419-2","article-title":"Patient-derived xenograft models in cancer therapy: technologies and applications","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215015_bb0030","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2217\/mmt.15.4","article-title":"Understanding melanoma stem cells","volume":"2","author":"Nguyen","year":"2015","journal-title":"Melanoma Manag."},{"issue":"11","key":"10.1016\/j.bioadv.2026.215015_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112831","article-title":"A soft matrix enhances the cancer stem cell phenotype of HCC cells","volume":"20","author":"Tian","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215015_bb0040","article-title":"Mechanical softness: a true stemness feature for cancer cells","volume":"8","author":"Lv","year":"2021","journal-title":"Mol. Cell. Oncol."},{"issue":"9","key":"10.1016\/j.bioadv.2026.215015_bb0045","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41419-021-04116-6","article-title":"The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215015_bb0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13058-024-01794-w","article-title":"Factors associated with engraftment success of patient-derived xenografts of breast cancer","volume":"26","author":"Lee","year":"2024","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215015_bb0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.7150\/jca.51749","article-title":"The essential factors of establishing patient-derived tumor model","volume":"12","author":"Chen","year":"2021","journal-title":"J. Cancer"},{"issue":"17","key":"10.1016\/j.bioadv.2026.215015_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15174352","article-title":"Challenges and prospects of patient-derived xenografts for cancer research","volume":"15","author":"Jin","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioadv.2026.215015_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.711381","article-title":"From donor to the lab: a fascinating journey of primary cell lines","volume":"9","author":"Richter","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"19\u201320","key":"10.1016\/j.bioadv.2026.215015_bb0070","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1101\/gad.329771.119","article-title":"Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities","volume":"33","author":"Rambow","year":"2019","journal-title":"Genes Dev."},{"issue":"2025","key":"10.1016\/j.bioadv.2026.215015_bb0075","article-title":"Advancements and challenges in culturing patient-derived cancer cells for personalized therapeutics","volume":"4","author":"Fu","year":"2025","journal-title":"Front. Lab Chip Technol."},{"issue":"7718","key":"10.1016\/j.bioadv.2026.215015_bb0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","article-title":"Genetic and transcriptional evolution alters cancer cell line drug response","volume":"560","author":"Ben-David","year":"2018","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bioadv.2026.215015_bb0085","first-page":"910","article-title":"2D and 3D cell cultures - a comparison of different types of cancer cell cultures","volume":"14","author":"Kapa\u0142czy\u0144ska","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.bioadv.2026.215015_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122408","article-title":"A comprehensive review on 3D tissue models: biofabrication technologies and preclinical applications","volume":"304","author":"Xie","year":"2024","journal-title":"Biomaterials"},{"issue":"17","key":"10.1016\/j.bioadv.2026.215015_bb0095","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1016\/j.cell.2024.07.042","article-title":"In vitro human cell-based models: what can they do and what are their limitations?","volume":"187","author":"Lutolf","year":"2024","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.bioadv.2026.215015_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12070602","article-title":"The overview of porous, bioactive scaffolds as instructive biomaterials for tissue regeneration and their clinical translation","volume":"12","author":"Lutzweiler","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2026.215015_bb0105","first-page":"15","article-title":"Decellularized extracellular matrix scaffolds: recent trends and emerging strategies in tissue engineering","volume":"10","author":"Zhang","year":"2022","journal-title":"Bioact. Mater."},{"issue":"3","key":"10.1016\/j.bioadv.2026.215015_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031166","article-title":"Spheroid culture differentially affects cancer cell sensitivity to drugs in melanoma and RCC models","volume":"23","author":"Filipiak-Duliban","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioadv.2026.215015_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2024.103058","article-title":"Protocol to generate scaffold-free, multicomponent 3D melanoma spheroid models for preclinical drug testing","volume":"5","author":"Angeli","year":"2024","journal-title":"STAR Protocol."},{"issue":"13","key":"10.1016\/j.bioadv.2026.215015_bb0120","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.23649","article-title":"Targeting the cyclin dependent kinase and retinoblastoma axis overcomes standard of care resistance in BRAF V600E -mutant melanoma","volume":"9","author":"Harris","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bioadv.2026.215015_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8030034","article-title":"Melanoma cancer stem cells: markers and functions","volume":"8","author":"Parmiani","year":"2016","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10.1016\/j.bioadv.2026.215015_bb0130","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1158\/0008-5472.CAN-14-0582","article-title":"ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit","volume":"74","author":"Wilson","year":"2014","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.bioadv.2026.215015_bb0135","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1701350","article-title":"Melanoma topology reveals a stem-like phenotype that promotes angiogenesis","volume":"3","author":"Lee","year":"2017","journal-title":"Sci. Adv."},{"issue":"8","key":"10.1016\/j.bioadv.2026.215015_bb0140","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nmat4610","article-title":"Interfacial geometry dictates cancer cell tumorigenicity","volume":"15","author":"Lee","year":"2016","journal-title":"Nat. Mater."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215015_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-020-1067-1","article-title":"Geometric regulation of histone state directs melanoma reprogramming","volume":"3","author":"Lee","year":"2020","journal-title":"Commun. Biol."},{"issue":"14","key":"10.1016\/j.bioadv.2026.215015_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202201696","article-title":"Hydrogel microtumor arrays to evaluate nanotherapeutics","volume":"12","author":"Liu","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"7","key":"10.1016\/j.bioadv.2026.215015_bb0155","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1158\/0008-5472.CAN-24-0394","article-title":"The rigidity connection: matrix stiffness and its impact on cancer progression","volume":"84","author":"Yui","year":"2024","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bioadv.2026.215015_bb0160","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","article-title":"Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy","volume":"15","author":"Mai","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215015_bb0165","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","article-title":"Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer","volume":"14","author":"Zhang","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215015_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cells13010096","article-title":"Extracellular matrix cues regulate mechanosensing and mechanotransduction of cancer cells","volume":"13","author":"Mierke","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bioadv.2026.215015_bb0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-030-14366-4_6","article-title":"Heterogeneity of melanoma with stem cell properties","volume":"1139","author":"Seftor","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215015_bb0180","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1158\/2159-8290.CD-21-1357","article-title":"The spatial landscape of progression and immunoediting in primary melanoma at single-cell resolution","volume":"12","author":"Nirmal","year":"2022","journal-title":"Cancer Discov."},{"issue":"13","key":"10.1016\/j.bioadv.2026.215015_bb0185","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1470-2045(15)00087-X","volume":"16","author":"Grob","year":"2015","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.bioadv.2026.215015_bb0190","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1056\/NEJMoa1904059","article-title":"Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma","volume":"381","author":"Robert","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bioadv.2026.215015_bb0195","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/annonc\/mdx176","article-title":"Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E\/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study","volume":"28","author":"Long","year":"2017","journal-title":"Ann. Oncol."},{"issue":"S7","key":"10.1016\/j.bioadv.2026.215015_bb0200","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/ajco.12656","article-title":"Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: guidelines from Australian melanoma medical oncologists","volume":"12","author":"Atkinson","year":"2016","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215015_bb0205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"issue":"W1","key":"10.1016\/j.bioadv.2026.215015_bb0210","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215015_bb0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215015_bb0220","first-page":"5","article-title":"Annexin A2 and cancer: a systematic review","volume":"52","author":"Christensen","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bioadv.2026.215015_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1108167","article-title":"ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: a systematic pan-cancer analysis","volume":"14","author":"Ning","year":"2023","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215015_bb0230","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1038\/s41467-022-30323-6","article-title":"A cancer-associated RNA polymerase III identity drives robust transcription and expression of snaR-A noncoding RNA","volume":"13","author":"Van Bortle","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215015_bb0235","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12885-024-12039-6","article-title":"Pan-cancer analysis of NUP155 and validation of its role in breast cancer cell proliferation, migration, and apoptosis","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cancer"},{"issue":"15","key":"10.1016\/j.bioadv.2026.215015_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153624","article-title":"Targeting long chain acyl-CoA synthetases for cancer therapy","volume":"20","author":"Rossi Sebastiano","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioadv.2026.215015_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153993","article-title":"PBXIP1 \u2013 an indicator for poor outcome and metastatic spread in colorectal cancer","volume":"236","author":"Ilmer","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bioadv.2026.215015_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1372873","article-title":"PBX1: a TALE of two seasons\u2014key roles during development and in cancer","volume":"12","author":"Crisafulli","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bioadv.2026.215015_bb0255","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1740936","article-title":"Cancer stem cell quiescence and plasticity as major challenges in cancer therapy","volume":"2016","author":"Chen","year":"2016","journal-title":"Stem Cells Int."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215015_bb0260","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41419-020-2669-8","article-title":"The emerging role of cancer cell plasticity and cell-cycle quiescence in immune escape","volume":"11","author":"Bruschini","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bioadv.2026.215015_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.742839","article-title":"VDAC modulation of cancer metabolism: advances and therapeutic challenges","volume":"12","author":"Heslop","year":"2021","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.bioadv.2026.215015_bb0270","article-title":"Patient-derived xenograft models: current status, challenges, and innovations in cancer research","volume":"12","author":"Liu","year":"2025","journal-title":"Genes Dis."},{"issue":"9","key":"10.1016\/j.bioadv.2026.215015_bb0275","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1158\/2159-8290.CD-14-0001","article-title":"Patient-derived xenograft models: an emerging platform for translational cancer research","volume":"4","author":"Hidalgo","year":"2014","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.bioadv.2026.215015_bb0280","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/pcmr.12023","article-title":"Society for Melanoma Research 2012 Congress","volume":"25","year":"2012","journal-title":"Pigm. Cell Melanoma Res."},{"issue":"1","key":"10.1016\/j.bioadv.2026.215015_bb0285","doi-asserted-by":"crossref","first-page":"10.16.1","DOI":"10.1002\/0471143030.cb1016s47","article-title":"Preparation of hydrogel substrates with tunable mechanical properties","volume":"47","author":"Tse","year":"2010","journal-title":"Curr. Protoc. Cell Biol."},{"issue":"27","key":"10.1016\/j.bioadv.2026.215015_bb0290","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1039\/c2sm25533b","article-title":"A novel technique for micro-patterning proteins and cells on polyacrylamide gels","volume":"8","author":"Tang","year":"2012","journal-title":"Soft Matter"},{"key":"10.1016\/j.bioadv.2026.215015_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fnana.2020.582218","article-title":"Immunofluorescence staining of paraffin sections step by step","volume":"14","author":"Zaqout","year":"2020","journal-title":"Front. Neuroanat."},{"issue":"20","key":"10.1016\/j.bioadv.2026.215015_bb0300","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1021\/ac025747h","article-title":"Empirical statistical model to estimate the accuracy of peptide identifications made by MS\/MS and database search","volume":"74","author":"Keller","year":"2002","journal-title":"Anal. Chem."},{"issue":"17","key":"10.1016\/j.bioadv.2026.215015_bb0305","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1021\/ac0341261","article-title":"A statistical model for identifying proteins by tandem mass spectrometry","volume":"75","author":"Nesvizhskii","year":"2003","journal-title":"Anal. Chem."}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826003134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950826003134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T21:33:32Z","timestamp":1786052012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950826003134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":61,"alternative-id":["S2772950826003134"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215015","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrogel microtumor arrays of patient melanoma recapitulate phenotypes and drug sensitivity","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2026.215015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"215015"}}